A study in healthy volunteers to assess the tolerability and blood levels of a single dose of AZD7687

Study identifier:D2710C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomized, blind, placebo-controlled, single-centre phase I study in healthy volunteers to assess the safety, tolerability and pharmacokinetics of AZD7687 after single ascending oral doses

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD7687, Placebo

Sex

Male

Actual Enrollment

64

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Nov 2009
Primary Completion Date: 01 Jun 2010
Study Completion Date: 01 Jun 2010

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Double Blind
Primary Purpose: Other

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria